FDA
label_change
· 2009-05-01
FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved Teva's supplemental application for glyburide, resulting in a labeling update for the generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLYBURIDE (GLYBURIDE)